Chao Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chao Li has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Bao-Wen Zhang
Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry Chinese Academy of Sciences, Beijing 100190, P. R. China
1 shared publicationNa Tian
Key Laboratory of Photochemical Conversion and Optoelectronic Materials
1 shared publicationNa-Na Tian
Key Laboratory of Photochemical Conversion and Optoelectronic Materials
1 shared publicationQian-Xiong Zhou
Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry Chinese Academy of Sciences, Beijing 100190, P. R. China
1 shared publication- Xuesong Wang
Chinese Academy of Sciences
1 shared publication Yuan-Jun Hou
Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry Chinese Academy of Sciences, Beijing 100190, P. R. China
1 shared publication
Latest Publications
- 13 November 2017
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 41 (24) , 14843-14846
Syntheses of 7-dehydrocholesterol peroxides and their improved anticancer activity and selectivity over ergosterol peroxide
7-Dehydrocholesterol peroxide (5α,8α-epidioxycholest-6-ene-3β-ol, CEP) and its acetate and hemisuccinate derivatives were synthesized and isolated for the first time, which exhibit improved anticancer activity and selectivity over ergosterol peroxide (5α,8α-epidioxy-22E-ergosta-6,22-dien-3β-ol, EEP), showing potential as new chemotherapeutic agents.
- 13 November 2017
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 41 (24) , 14843-14846
Syntheses of 7-dehydrocholesterol peroxides and their improved anticancer activity and selectivity over ergosterol peroxide
7-Dehydrocholesterol peroxide (5α,8α-epidioxycholest-6-ene-3β-ol, CEP) and its acetate and hemisuccinate derivatives were synthesized and isolated for the first time, which exhibit improved anticancer activity and selectivity over ergosterol peroxide (5α,8α-epidioxy-22E-ergosta-6,22-dien-3β-ol, EEP), showing potential as new chemotherapeutic agents.